Shlobin OA - Search Results

1

Pulmonary hypertension associated with lung diseases.

Shlobin OA, Adir Y, Barbera JA, Cottin V, Harari S, Jutant EM, Pepke-Zaba J, Ghofrani HA, Channick R. Shlobin OA, et al. Eur Respir J. 2024 Oct 31;64(4):2401200. doi: 10.1183/13993003.01200-2024. Print 2024 Oct. Eur Respir J. 2024. PMID: 39209469 Free PMC article. Review.

2

Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.

Nathan SD, Shlobin OA, Barnett SD, Saggar R, Belperio JA, Ross DJ, Ahmad S, Saggar R, Libre E, Lynch JP 3rd, Zisman DA. Nathan SD, et al. Among authors: shlobin oa. Respir Med. 2008 Sep;102(9):1305-10. doi: 10.1016/j.rmed.2008.03.022. Epub 2008 Jul 10. Respir Med. 2008. PMID: 18619825 Free PMC article.

3

Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis.

Nathan SD, Basavaraj A, Reichner C, Shlobin OA, Ahmad S, Kiernan J, Burton N, Barnett SD. Nathan SD, et al. Among authors: shlobin oa. Respir Med. 2010 Jul;104(7):1035-41. doi: 10.1016/j.rmed.2010.02.008. Epub 2010 Mar 2. Respir Med. 2010. PMID: 20199856 Free article.

4

Pulmonary hypertension secondary to interstitial lung disease.

Shlobin OA, Nathan SD. Shlobin OA, et al. Expert Rev Respir Med. 2011 Apr;5(2):179-89. doi: 10.1586/ers.11.11. Expert Rev Respir Med. 2011. PMID: 21510729 Review.

5

Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation.

Shlobin OA, Nathan SD. Shlobin OA, et al. Eur Respir J. 2012 Jun;39(6):1520-33. doi: 10.1183/09031936.00175511. Epub 2012 Jan 12. Eur Respir J. 2012. PMID: 22241743 Free article. Review.

6

Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease.

Shin S, King CS, Brown AW, Albano MC, Atkins M, Sheridan MJ, Ahmad S, Newton KM, Weir N, Shlobin OA, Nathan SD. Shin S, et al. Among authors: shlobin oa. Respir Med. 2014 Nov;108(11):1626-32. doi: 10.1016/j.rmed.2014.08.009. Epub 2014 Sep 2. Respir Med. 2014. PMID: 25225149 Free article.

7

Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.

Shin S, King CS, Puri N, Shlobin OA, Brown AW, Ahmad S, Weir NA, Nathan SD. Shin S, et al. Among authors: shlobin oa. Eur Respir J. 2016 May;47(5):1445-51. doi: 10.1183/13993003.01532-2015. Epub 2016 Feb 4. Eur Respir J. 2016. PMID: 26846836 Free article.

8

Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.

Shlobin OA, Brown AW, Nathan SD. Shlobin OA, et al. Chest. 2017 Jan;151(1):204-214. doi: 10.1016/j.chest.2016.08.002. Epub 2016 Aug 20. Chest. 2017. PMID: 27554299 Review.

9

Sarcoidosis-Associated Pulmonary Hypertension.

Shlobin OA, Baughman RP. Shlobin OA, et al. Semin Respir Crit Care Med. 2017 Aug;38(4):450-462. doi: 10.1055/s-0037-1603767. Epub 2017 Jul 27. Semin Respir Crit Care Med. 2017. PMID: 28750460 Review. No abstract available.

10

Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far.

Baughman RP, Shlobin OA. Baughman RP, et al. Among authors: shlobin oa. Eur Respir J. 2017 Oct 19;50(4):1701725. doi: 10.1183/13993003.01725-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29051277 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters